Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
CC transcript
Appointed director
Inv. presentation
Appointed CFO
|
|
PDL BIOPHARMA, INC. (PDLI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/03/2021 |
4
| Silver Point Capital L.P. (10% Owner) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Bought 187,061 shares
@ $2.05, valued at
$383.5k
|
|
| 01/11/2021 |
3
| Park West Asset Management LLC (10% Owner) has filed a Form 3 on PDL BIOPHARMA, INC. |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2020 |
4
| Silver Point Capital L.P. (10% Owner) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Bought 128,000 shares
@ $2.65, valued at
$339.2k
Bought 235,000 shares
@ $2.7, valued at
$634.5k
Bought 268,600 shares
@ $2.69, valued at
$722.5k
|
|
| 12/23/2020 |
4
| Silver Point Capital L.P. (10% Owner) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Bought 230,000 shares
@ $2.63, valued at
$604.9k
Bought 850,000 shares
@ $2.59, valued at
$2.2M
Bought 485,000 shares
@ $2.6, valued at
$1.3M
|
|
| 12/22/2020 |
4
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 50,000 shares
@ $2.624, valued at
$131.2k
Sold 277,934 shares
@ $2.607, valued at
$724.6k
|
|
| 12/18/2020 |
4
| Silver Point Capital L.P. (10% Owner) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Bought 1,350,000 shares
@ $2.58, valued at
$3.5M
Bought 398,000 shares
@ $2.61, valued at
$1M
|
|
| 12/17/2020 |
4
| Stone Christopher Lewis (VP, Gen. Counsel & Secretary) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 200,000 shares
@ $2.56, valued at
$512k
|
|
| 12/17/2020 |
4
| Monnet Dominique (President and CEO) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 500,000 shares
@ $2.6, valued at
$1.3M
|
|
| 12/17/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 75,000 shares
@ $2.68, valued at
$201k
|
|
| 12/15/2020 |
4
| Silver Point Capital L.P. (10% Owner) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Bought 450,000 shares
@ $2.45, valued at
$1.1M
Bought 640,000 shares
@ $2.62, valued at
$1.7M
Bought 1,000,000 shares
@ $2.59, valued at
$2.6M
|
|
| 12/15/2020 |
3
| Silver Point Capital L.P. (10% Owner) has filed a Form 3 on PDL BIOPHARMA, INC. |
| 12/09/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Exercised 66,050 options to buy
@ $1.64, valued at
$108.3k
|
|
| 12/04/2020 |
4
| Stone Christopher Lewis (VP, Gen. Counsel & Secretary) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Disposed/sold 11,544 shares
@ $0 |
|
| 12/04/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 75,000 shares
@ $2.52, valued at
$189k
|
|
| 11/24/2020 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 25,826 shares
@ $2.44, valued at
$63k
|
|
| 11/24/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 50,000 shares
@ $2.43, valued at
$121.5k
|
|
| 11/20/2020 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 63,291 shares
@ $2.381, valued at
$150.7k
|
|
| 11/20/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Exercised 60,000 options to buy
@ $1.64, valued at
$98.4k
|
|
| 11/20/2020 |
4
| Bazaar Alan Lee (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Paid exercise price by delivering 26,642 shares
@ $2.38, valued at
$63.4k
Sold 33,435 shares
@ $2.4227, valued at
$81k
Exercised 37,080 options to buy
@ $1.71, valued at
$63.4k
|
|
| 11/19/2020 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 100,000 shares
@ $2.4, valued at
$240k
Sold 50,000 shares
@ $2.39, valued at
$119.5k
|
|
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2020 |
3
| PDL BIOPHARMA, INC. (10% Owner) has filed a Form 3 on LENSAR, Inc. |
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2020 |
4
| PDL BIOPHARMA, INC. (10% Owner) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Disposed of 13,333,334 shares
@ $0 |
|
| 04/21/2020 |
4
| Bazaar Alan Lee (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 7,609 shares
@ $0
Granted 37,080 options to buy
@ $3.07, valued at
$113.8k
|
|
| 04/21/2020 |
3
| Bazaar Alan Lee (Director) has filed a Form 3 on PDL BIOPHARMA, INC. |
| 04/07/2020 |
4
| Stone Christopher Lewis (VP, Gen. Counsel & Secretary) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Paid exercise price by delivering 1,240 shares
@ $3.43, valued at
$4.3k
Paid exercise price by delivering 2,686 shares
@ $3.33, valued at
$8.9k
|
|
| 04/07/2020 |
4/A
| Imbrogno Edward (VP Finance, CAO and Acting CFO) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 292,208 shares
@ $0 |
|
|
|
|